ATE410164T1 - Wässrige flüssige preparation von pranoprofen - Google Patents
Wässrige flüssige preparation von pranoprofenInfo
- Publication number
- ATE410164T1 ATE410164T1 AT01932087T AT01932087T ATE410164T1 AT E410164 T1 ATE410164 T1 AT E410164T1 AT 01932087 T AT01932087 T AT 01932087T AT 01932087 T AT01932087 T AT 01932087T AT E410164 T1 ATE410164 T1 AT E410164T1
- Authority
- AT
- Austria
- Prior art keywords
- pranoprofen
- aqueous liquid
- liquid preparation
- aqueous solution
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/14—Nitrogen atoms
- C07D261/16—Benzene-sulfonamido isoxazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000145640 | 2000-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE410164T1 true ATE410164T1 (de) | 2008-10-15 |
Family
ID=18652118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01932087T ATE410164T1 (de) | 2000-05-17 | 2001-05-16 | Wässrige flüssige preparation von pranoprofen |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1283042B1 (de) |
JP (1) | JP4754149B2 (de) |
KR (1) | KR100776579B1 (de) |
CN (1) | CN1210028C (de) |
AT (1) | ATE410164T1 (de) |
AU (1) | AU2001258754A1 (de) |
DE (1) | DE60136064D1 (de) |
ES (1) | ES2310550T3 (de) |
PT (1) | PT1283042E (de) |
WO (1) | WO2001087303A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5785353B2 (ja) * | 2004-02-27 | 2015-09-30 | 大正製薬株式会社 | 眼科用剤 |
JP2005247803A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 点眼剤及びその容器 |
JP2005247801A (ja) * | 2004-03-08 | 2005-09-15 | Zeria Pharmaceut Co Ltd | 安定な点眼剤 |
JP4845405B2 (ja) * | 2004-03-29 | 2011-12-28 | ロート製薬株式会社 | プラノプロフェン含有医薬製剤 |
JP5623684B2 (ja) * | 2006-10-13 | 2014-11-12 | ゼリア新薬工業株式会社 | 眼科用剤 |
JP6009141B2 (ja) * | 2009-10-09 | 2016-10-19 | ロート製薬株式会社 | 水性組成物 |
JP5992293B2 (ja) * | 2012-10-31 | 2016-09-14 | 大正製薬株式会社 | 眼科用剤 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60184013A (ja) * | 1984-03-01 | 1985-09-19 | Yoshitomi Pharmaceut Ind Ltd | 点眼剤 |
JPH05186349A (ja) * | 1991-12-30 | 1993-07-27 | Teika Seiyaku Kk | プラノプロフェン点眼剤組成物 |
JP3170619B2 (ja) * | 1995-04-20 | 2001-05-28 | 参天製薬株式会社 | 有機アミンを配合したプラノプロフェン点眼液 |
JPH10236951A (ja) * | 1996-12-27 | 1998-09-08 | Teika Seiyaku Kk | プラノプロフェン配合点眼剤 |
JPH10295777A (ja) * | 1997-04-28 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 安定な抗菌点眼剤 |
-
2001
- 2001-05-16 CN CNB018096352A patent/CN1210028C/zh not_active Expired - Lifetime
- 2001-05-16 JP JP2001583771A patent/JP4754149B2/ja not_active Expired - Lifetime
- 2001-05-16 WO PCT/JP2001/004083 patent/WO2001087303A1/ja active Application Filing
- 2001-05-16 AU AU2001258754A patent/AU2001258754A1/en not_active Abandoned
- 2001-05-16 DE DE60136064T patent/DE60136064D1/de not_active Expired - Fee Related
- 2001-05-16 KR KR1020027015286A patent/KR100776579B1/ko active IP Right Grant
- 2001-05-16 EP EP01932087A patent/EP1283042B1/de not_active Expired - Lifetime
- 2001-05-16 ES ES01932087T patent/ES2310550T3/es not_active Expired - Lifetime
- 2001-05-16 PT PT01932087T patent/PT1283042E/pt unknown
- 2001-05-16 AT AT01932087T patent/ATE410164T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2001258754A1 (en) | 2001-11-26 |
EP1283042B1 (de) | 2008-10-08 |
CN1210028C (zh) | 2005-07-13 |
JP4754149B2 (ja) | 2011-08-24 |
KR20020094052A (ko) | 2002-12-16 |
WO2001087303A1 (fr) | 2001-11-22 |
EP1283042A4 (de) | 2007-05-23 |
DE60136064D1 (de) | 2008-11-20 |
ES2310550T3 (es) | 2009-01-16 |
PT1283042E (pt) | 2008-11-19 |
CN1438887A (zh) | 2003-08-27 |
EP1283042A1 (de) | 2003-02-12 |
KR100776579B1 (ko) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1605932T3 (da) | Intranasal formulering af rotigotin | |
BR9906735A (pt) | Composição farmacêutica lìquida aquosa | |
BRPI0414541B8 (pt) | compostos heterocíclicos fundidos tendo atividade de modulação de receptor de serotonina, método de preparação de compostos intermediários | |
EA200300211A1 (ru) | Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств | |
DK1343782T3 (da) | Pyrimidinaminer som angiogenesemodulatorer | |
CY1105247T1 (el) | Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης | |
BR0112969A (pt) | Método de utilização de dicetopiperazinas e composições contendo-as | |
NO20061840L (no) | Legemiddelbelegg som tilveiebringer hoy legemiddeltilsetning og fremgangsmater for a tilveiebringe samme | |
NO20031273D0 (no) | Substituerte kanelsyreguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som legemiddel og legemiddel som inneholder de samme | |
DE50213681D1 (de) | Wässrige Lösung von Ascorbinsäure | |
EA200200492A1 (ru) | Растворы, содержащие эпинастин | |
NO20025081L (no) | Stabilt flytende preparat | |
TR200100895T2 (tr) | Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı | |
DE60136064D1 (de) | Wässrige flüssige preparation von pranoprofen | |
DK1397681T3 (da) | Fremgangsmåde til identificering af midler til behandling af diabetes | |
DE60006558D1 (de) | Stabile lösung von calcitriol zum verpacken in phiolen | |
EA200300727A1 (ru) | Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции | |
EA200101150A1 (ru) | Раствор прукалоприда для перорального применения | |
ATE428691T1 (de) | 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha | |
BR0110490A (pt) | Agentes de tingimento contendo derivados de n-heteroarilmetil-m-fenilenodiamina para fibras de queratina bem como novos derivados de n-heteroarilmetil-m-fenilenodiamina | |
DK1268522T3 (da) | LH-RH-antagonister samt fremstilling deraf og anvendelse deraf som lægemidler | |
EA200400751A1 (ru) | Применение дезоксипеганина для лечения клинической депрессии | |
PT1150660E (pt) | Formulacao farmaceutica efervescente contendo metamizole | |
BR0114459A (pt) | Derivados substituìdos de 5-amino-1-penten-3-ol substituidos | |
BR0211323A (pt) | Combinação de ingredientes ativos, uso de uma combinação de ingredientes ativos e método de terapia farmacológica de dependência de nicotina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |